img

Global In-Vitro Cancer Diagnostics Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global In-Vitro Cancer Diagnostics Market Insights, Forecast to 2034

In-vitro cancer diagnostics are medical tests and assays used to detect and diagnose cancer using patient samples, such as blood, tissue, or urine.
Market Analysis and InsightsGlobal In-Vitro Cancer Diagnostics Market
Global In-Vitro Cancer Diagnostics market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, In-Vitro Cancer Diagnostics industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The market for in-vitro cancer diagnostics is driven by the growing burden of cancer and the need for early and accurate cancer detection. The market's growth is also influenced by the development of novel biomarkers and advanced diagnostic technologies, leading to improved sensitivity and specificity of cancer tests.
Report Covers
This report presents an overview of global In-Vitro Cancer Diagnostics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global In-Vitro Cancer Diagnostics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
Burning Rock
Novogene
Geneseeq
Amoy Diagnostics Co.,Ltd.
Daan Gene
Fosun Pharma
Segment by Type
Instruments
Reagents and Kits

Segment by Application


Laboratories
Hospitals
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, In-Vitro Cancer Diagnostics introduction, etc. In-Vitro Cancer Diagnostics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of In-Vitro Cancer Diagnostics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2018-2029)
2.2 Global In-Vitro Cancer Diagnostics Growth Trends by Region
2.2.1 In-Vitro Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 In-Vitro Cancer Diagnostics Historic Market Size by Region (2018-2024)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 In-Vitro Cancer Diagnostics Market Dynamics
2.3.1 In-Vitro Cancer Diagnostics Industry Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue In-Vitro Cancer Diagnostics by Players
3.1.1 Global In-Vitro Cancer Diagnostics Revenue by Players (2018-2024)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2018-2024)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of In-Vitro Cancer Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2022
3.5 Global Key Players of In-Vitro Cancer Diagnostics Head office and Area Served
3.6 Global Key Players of In-Vitro Cancer Diagnostics, Product and Application
3.7 Global Key Players of In-Vitro Cancer Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2018-2024)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2018-2024)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2018-2029)
6.2 North America In-Vitro Cancer Diagnostics Market Size by Type
6.2.1 North America In-Vitro Cancer Diagnostics Market Size by Type (2018-2024)
6.2.2 North America In-Vitro Cancer Diagnostics Market Size by Type (2024-2029)
6.2.3 North America In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
6.3 North America In-Vitro Cancer Diagnostics Market Size by Application
6.3.1 North America In-Vitro Cancer Diagnostics Market Size by Application (2018-2024)
6.3.2 North America In-Vitro Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 North America In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country
6.4.1 North America In-Vitro Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2018-2024)
6.4.3 North America In-Vitro Cancer Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2018-2029)
7.2 Europe In-Vitro Cancer Diagnostics Market Size by Type
7.2.1 Europe In-Vitro Cancer Diagnostics Market Size by Type (2018-2024)
7.2.2 Europe In-Vitro Cancer Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Application
7.3.1 Europe In-Vitro Cancer Diagnostics Market Size by Application (2018-2024)
7.3.2 Europe In-Vitro Cancer Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country
7.4.1 Europe In-Vitro Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2018-2024)
7.4.3 Europe In-Vitro Cancer Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China In-Vitro Cancer Diagnostics Market Size (2018-2029)
8.2 China In-Vitro Cancer Diagnostics Market Size by Type
8.2.1 China In-Vitro Cancer Diagnostics Market Size by Type (2018-2024)
8.2.2 China In-Vitro Cancer Diagnostics Market Size by Type (2024-2029)
8.2.3 China In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
8.3 China In-Vitro Cancer Diagnostics Market Size by Application
8.3.1 China In-Vitro Cancer Diagnostics Market Size by Application (2018-2024)
8.3.2 China In-Vitro Cancer Diagnostics Market Size by Application (2024-2029)
8.3.3 China In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia In-Vitro Cancer Diagnostics Market Size (2018-2029)
9.2 Asia In-Vitro Cancer Diagnostics Market Size by Type
9.2.1 Asia In-Vitro Cancer Diagnostics Market Size by Type (2018-2024)
9.2.2 Asia In-Vitro Cancer Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
9.3 Asia In-Vitro Cancer Diagnostics Market Size by Application
9.3.1 Asia In-Vitro Cancer Diagnostics Market Size by Application (2018-2024)
9.3.2 Asia In-Vitro Cancer Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
9.4 Asia In-Vitro Cancer Diagnostics Market Size by Region
9.4.1 Asia In-Vitro Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia In-Vitro Cancer Diagnostics Market Size by Region (2018-2024)
9.4.3 Asia In-Vitro Cancer Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Details
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.1.5 MDx Health Quest Diagnostics Recent Developments
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Details
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.2.5 R-Biopharm AG Recent Developments
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Details
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.3.5 Signature Diagnostics Recent Developments
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.4.5 Siemens Healthcare Recent Developments
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Details
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.5.5 Randox Laboratories Recent Developments
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Details
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.6.5 Epigenomics AG Recent Developments
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.7.5 Beckman Coulter Recent Developments
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.8.5 Abbott Laboratories Recent Developments
11.9 Burning Rock
11.9.1 Burning Rock Company Details
11.9.2 Burning Rock Business Overview
11.9.3 Burning Rock In-Vitro Cancer Diagnostics Introduction
11.9.4 Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.9.5 Burning Rock Recent Developments
11.10 Novogene
11.10.1 Novogene Company Details
11.10.2 Novogene Business Overview
11.10.3 Novogene In-Vitro Cancer Diagnostics Introduction
11.10.4 Novogene Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.10.5 Novogene Recent Developments
11.11 Geneseeq
11.11.1 Geneseeq Company Details
11.11.2 Geneseeq Business Overview
11.11.3 Geneseeq In-Vitro Cancer Diagnostics Introduction
11.11.4 Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.11.5 Geneseeq Recent Developments
11.12 Amoy Diagnostics Co.,Ltd.
11.12.1 Amoy Diagnostics Co.,Ltd. Company Details
11.12.2 Amoy Diagnostics Co.,Ltd. Business Overview
11.12.3 Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Introduction
11.12.4 Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.12.5 Amoy Diagnostics Co.,Ltd. Recent Developments
11.13 Daan Gene
11.13.1 Daan Gene Company Details
11.13.2 Daan Gene Business Overview
11.13.3 Daan Gene In-Vitro Cancer Diagnostics Introduction
11.13.4 Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.13.5 Daan Gene Recent Developments
11.14 Fosun Pharma
11.14.1 Fosun Pharma Company Details
11.14.2 Fosun Pharma Business Overview
11.14.3 Fosun Pharma In-Vitro Cancer Diagnostics Introduction
11.14.4 Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2018-2024)
11.14.5 Fosun Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents and Kits
Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global In-Vitro Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global In-Vitro Cancer Diagnostics Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global In-Vitro Cancer Diagnostics Market Share by Region (2018-2024)
Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global In-Vitro Cancer Diagnostics Market Share by Region (2024-2029)
Table 10. In-Vitro Cancer Diagnostics Market Trends
Table 11. In-Vitro Cancer Diagnostics Market Drivers
Table 12. In-Vitro Cancer Diagnostics Market Challenges
Table 13. In-Vitro Cancer Diagnostics Market Restraints
Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global In-Vitro Cancer Diagnostics Revenue Share by Players (2018-2024)
Table 16. Global Top In-Vitro Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2022)
Table 17. Global In-Vitro Cancer Diagnostics Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of In-Vitro Cancer Diagnostics, Headquarters and Area Served
Table 20. Global Key Players of In-Vitro Cancer Diagnostics, Product and Application
Table 21. Global Key Players of In-Vitro Cancer Diagnostics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2018-2024)
Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 27. Global In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global In-Vitro Cancer Diagnostics Revenue Share by Application (2018-2024)
Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global In-Vitro Cancer Diagnostics Revenue Share by Application (2024-2029)
Table 31. North America In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America In-Vitro Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America In-Vitro Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America In-Vitro Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America In-Vitro Cancer Diagnostics Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America In-Vitro Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe In-Vitro Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe In-Vitro Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe In-Vitro Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe In-Vitro Cancer Diagnostics Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe In-Vitro Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 45. China In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 46. China In-Vitro Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 47. China In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 48. China In-Vitro Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia In-Vitro Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia In-Vitro Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia In-Vitro Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia In-Vitro Cancer Diagnostics Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia In-Vitro Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 63. MDx Health Quest Diagnostics Company Details
Table 64. MDx Health Quest Diagnostics Business Overview
Table 65. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product
Table 66. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 67. MDx Health Quest Diagnostics Recent Developments
Table 68. R-Biopharm AG Company Details
Table 69. R-Biopharm AG Business Overview
Table 70. R-Biopharm AG In-Vitro Cancer Diagnostics Product
Table 71. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 72. R-Biopharm AG Recent Developments
Table 73. Signature Diagnostics Company Details
Table 74. Signature Diagnostics Business Overview
Table 75. Signature Diagnostics In-Vitro Cancer Diagnostics Product
Table 76. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 77. Signature Diagnostics Recent Developments
Table 78. Siemens Healthcare Company Details
Table 79. Siemens Healthcare Business Overview
Table 80. Siemens Healthcare In-Vitro Cancer Diagnostics Product
Table 81. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 82. Siemens Healthcare Recent Developments
Table 83. Randox Laboratories Company Details
Table 84. Randox Laboratories Business Overview
Table 85. Randox Laboratories In-Vitro Cancer Diagnostics Product
Table 86. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 87. Randox Laboratories Recent Developments
Table 88. Epigenomics AG Company Details
Table 89. Epigenomics AG Business Overview
Table 90. Epigenomics AG In-Vitro Cancer Diagnostics Product
Table 91. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 92. Epigenomics AG Recent Developments
Table 93. Beckman Coulter Company Details
Table 94. Beckman Coulter Business Overview
Table 95. Beckman Coulter In-Vitro Cancer Diagnostics Product
Table 96. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 97. Beckman Coulter Recent Developments
Table 98. Abbott Laboratories Company Details
Table 99. Abbott Laboratories Business Overview
Table 100. Abbott Laboratories In-Vitro Cancer Diagnostics Product
Table 101. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 102. Abbott Laboratories Recent Developments
Table 103. Burning Rock Company Details
Table 104. Burning Rock Business Overview
Table 105. Burning Rock In-Vitro Cancer Diagnostics Product
Table 106. Burning Rock Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 107. Burning Rock Recent Developments
Table 108. Novogene Company Details
Table 109. Novogene Business Overview
Table 110. Novogene In-Vitro Cancer Diagnostics Product
Table 111. Novogene Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 112. Novogene Recent Developments
Table 113. Geneseeq Company Details
Table 114. Geneseeq Business Overview
Table 115. Geneseeq In-Vitro Cancer Diagnostics Product
Table 116. Geneseeq Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 117. Geneseeq Recent Developments
Table 118. Amoy Diagnostics Co.,Ltd. Company Details
Table 119. Amoy Diagnostics Co.,Ltd. Business Overview
Table 120. Amoy Diagnostics Co.,Ltd. In-Vitro Cancer Diagnostics Product
Table 121. Amoy Diagnostics Co.,Ltd. Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 122. Amoy Diagnostics Co.,Ltd. Recent Developments
Table 123. Daan Gene Company Details
Table 124. Daan Gene Business Overview
Table 125. Daan Gene In-Vitro Cancer Diagnostics Product
Table 126. Daan Gene Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 127. Daan Gene Recent Developments
Table 128. Fosun Pharma Company Details
Table 129. Fosun Pharma Business Overview
Table 130. Fosun Pharma In-Vitro Cancer Diagnostics Product
Table 131. Fosun Pharma Revenue in In-Vitro Cancer Diagnostics Business (2018-2024) & (US$ Million)
Table 132. Fosun Pharma Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global In-Vitro Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Instruments Features
Figure 4. Reagents and Kits Features
Figure 5. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global In-Vitro Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 7. Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Others Case Studies
Figure 10. In-Vitro Cancer Diagnostics Report Years Considered
Figure 11. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global In-Vitro Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 14. Global In-Vitro Cancer Diagnostics Market Share by Players in 2022
Figure 15. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Cancer Diagnostics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2022
Figure 17. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
Figure 19. North America In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
Figure 20. North America In-Vitro Cancer Diagnostics Market Share by Country (2018-2029)
Figure 21. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe In-Vitro Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
Figure 25. Europe In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
Figure 26. Europe In-Vitro Cancer Diagnostics Market Share by Country (2018-2029)
Figure 27. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China In-Vitro Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
Figure 35. China In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
Figure 36. Asia In-Vitro Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
Figure 38. Asia In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
Figure 39. Asia In-Vitro Cancer Diagnostics Market Share by Region (2018-2029)
Figure 40. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America In-Vitro Cancer Diagnostics Market Share by Country (2018-2029)
Figure 50. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries In-Vitro Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 57. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 58. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 59. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 60. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 61. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 62. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 63. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 64. Burning Rock Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 65. Novogene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 66. Geneseeq Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 67. Amoy Diagnostics Co.,Ltd. Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 68. Daan Gene Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 69. Fosun Pharma Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries